www.hhs.gov U.S. Department of Health and Human Services

Rare Diseases - Challenges and Progress in Drug Development

Enroll
Step Status
Educational Content ✘
Posttest ✘
Evaluation ✘
Starts On: Wed, 6/14/23: 12:00 AM EDT
Ends On: Sun, 6/14/26: 11:45 PM EDT
Type: Enduring Material
Credits: 1
Description: The development of drugs to treat rare diseases is challenging on multiple levels. This online learning will examine these challenges and FDA programs to drive scientific and regulatory innovation and engagement to accelerate the availability of treatments for patients with rare diseases.
Objectives:
  • Describe the challenges involved in developing a drug for a rare disease.
  • Identify key aspects of the FDA regulatory framework that are relevant to rare disease drug development.
  • Summarize the efforts of the FDA Center for Drug Evaluation and Research to accelerate rare disease drug development through innovation and engagement.
Additional Information: Review the Activity Announcement for additional details: Announcement Form

Additional Resources: SLIDES
ACCME Joint Accreditation
  • This warning banner provides privacy and security notices consistent with applicable federal laws, directives, and other federal guidance for accessing this Government system, which includes (1) this computer network, (2) all computers connected to this network, and (3) all devices and storage media attached to this network or to a computer on this network.
  • This system is provided for Government-authorized use only.
  • Unauthorized or improper use of this system is prohibited and may result in disciplinary action and/or civil and criminal penalties.
  • Personal use of social media and networking sites on this system is limited as to not interfere with official work duties and is subject to monitoring.
  • By using this system, you understand and consent to the following:
    • The Government may monitor, record, and audit your system usage, including usage of personal devices and email systems for official duties or to conduct HHS business. Therefore, you have no reasonable expectation of privacy regarding any communication or data transiting or stored on this system. At any time, and for any lawful Government purpose, the government may monitor, intercept, and search and seize any communication or data transiting or stored on this system.
    • Any communication or data transiting or stored on this system may be disclosed or used for any lawful Government purpose.